Find new businesses and brands
BYDURA
By: Amylin Pharmaceuticals, Inc. tweet it Tweet Logo Share on Facebook
Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, obesity, cardiovascular diseases and disorders, gastrointestinal disorders, immunological disorders, inflammation and inflammatory diseases, neurological disorders, pain, peripheral nervous system diseases and disor...

Perfect for these industries

Words that describe this logo

pharmaceutical   preparations       pharmaceutical   preparations   use   treatment   prevention   metabolic   disorders     endocrine   conditions   disorders     diabetes     diabetic   complications     hormonal   diseases   disorders     obesity  
This is a brand page for the BYDURA trademark by Amylin Pharmaceuticals, Inc. in San Diego, CA, 92121. Write a review about a product or service associated with this BYDURA trademark. Or, contact the owner Amylin Pharmaceuticals, Inc. of the BYDURA trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the BYDURA trademark.
On Tuesday, September 18, 2007, a U.S. federal trademark registration was filed for BYDURA by Amylin Pharmaceuticals, Inc., San Diego, CA 92121. The USPTO has given the BYDURA trademark serial number of 77282678. The current federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED. The correspondent listed for BYDURA is EDWARD D GRIEFF of AMYLIN PHARMACEUTICALS, INC., 9360 TOWNE CENTRE DR, LEGAL DEPARTMENT SAN DIEGO, CA 92121-3057 . The BYDURA trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for BYDURA is Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, obesity, cardiovascular diseases and disorders, gastrointestinal disorders, immunological disorders, inflammation and inflammatory diseases, neurological disorders, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, uro.
Word Mark: BYDURA
Status/
Status Date:
ABANDONED - NO STATEMENT OF USE FILED
5/31/2010

Serial Number: 77282678
Filing Date: 9/18/2007
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, obesity, cardiovascular diseases and disorders, gastrointestinal disorders, immunological disorders, inflammation and inflammatory diseases, neurological disorders, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, uro
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 8/4/2009
Last Applicant/Owner: Amylin Pharmaceuticals, Inc.
San Diego, CA 92121
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
AMYLIN PHARMACEUTICALS, INC.
9360 TOWNE CENTRE DR
LEGAL DEPARTMENT
SAN DIEGO, CA 92121-3057
Classification Information
International Class Code(s): 005
US Class Code(s): 006, 018, 044, 046, 051, 052
Primary Class: Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Class(es) Status: Active
First Use Anywhere: NOT PROVIDED
First Use In Commerce: NOT PROVIDED
 

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the LegalForce/Trademarkia network! You can register your trademark in 100+ countries in the world through LegalForce Network.

LegalForce Network can help you incorporate a business around your BYDURA trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>
trademark
100% Satisfaction Guarantee
protect your valuable brand now.
 
How it works?
  1. Legalforce RAPC - #1 U.S. Trademark Filer since 2010.
  2. Describe how your business or product is being used. Register your mark in 100+ countries. Just $159 + govt fees! Start here >>
What our customers say:
I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.
-Camryn, Surrey, UK
Keep Track of this Brand.
Trademark Watch Services
Keep track of how your trademark is being used. Available in the United States and in more than 100 countries. Round-the-clock monitoring. Monthly report on potential infringement.
Trademark Watch Services read more...
Current Trademark Status:
5/31/2010
ABANDONED - NO STATEMENT OF USE FILED
Free Trademark Search:
Search:
Correspondent Search:
EDWARD D GRIEFF is a correspondent of BYDURA trademark.
Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
 
Available, Get it at $159

This mark may be available for re-registration. You can apply for it through LegalForce Trademarkia at a low cost of $159!

Trademarkia.com will perform a final search in order to verify that this mark is available for re-registration. All Trademarkia services are backed by a 100% satisfaction guarantee.

Amylin Pharmaceuticals Increases Speed to Insight with 100 Million Rows
Published on:2/14/2013 3:50:02 PM
Morgan Stanley Said UW Rating On Amylin Pharma Was Based On Bydureon Launch Concerns
Published on:10/21/2010 10:46:08 AM
Amylin Pharmaceuticals Shares Rise After Rejecting Bid by Bristol-Myers Squibb
Published on:3/28/2012 7:45:38 AM
UCSD Amylin Pharmaceutical Scholarship Recipient
Published on:4/17/2007 6:23:52 PM
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!